| Application no. and date | 16744237.5 (espacenet) (Federated) (European Patent Register), 20160129 | | Patent/reg. no. and date | DK/EP 3250208, 20200930 | | Publication date | 20171206 | | Priority no. and date | US 201562109737 P, 20150130, US 201562148844 P, 20150417, US 201562233757 P, 20150928 | | EP pub. no. and date |
EP 3250208 20171206 | | Effective date | | | Applicant/owner | Oncoceutics, Inc., 3675 Market Street
Suite 200
Philadelphia, PA 19104, US | | Applicant ref. no. | | | Inventor | POTTORF, Richard S., 7550 Prairie View Dr.
Indianapolis, Indiana 46526, US,
NALLAGANCHU, Bhaskara Rao, 99 Nostrand Road
Hillsborough, New Jersey 08852, US,
SUN, Yanjun, 14 Greyhound Court
Kendall Park, New Jersey 08824, US,
STOGNIEW, Martin, 7811 Mathern Ct.
Lakewood Ranch,
Florida 34202, US,
ALLEN, Joshua E., 43 Chestnut St.,
Unit 311
New Haven, Connecticut 06511, US,
OLSON, Gary L., 1505 Coles Avenue
Mountainside, New Jersey 07092, US | | Representative | Potter Clarkson A/S, Regnbuepladsen 7, 1550 København V, DK | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , C07D 471/12 (2006.01) | | Title | 7-BENZYL-4-(4-(TRIFLUORMETHYL)BENZYL)-1,2,6,7,8,9-HEXAHYDROIMIDAZO[1,2-A]PYRIDO[3,4-E]PYRIMIDIN-5(4H)-ON OG SALTE DERAF SAMT ANVENDELSE DERAF I TERAPI | | Int. application no. | US2016015817 | | Int. publication no. | WO2016123571 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
